Kiley Grant is the Co-Founder and CEO of Oleolive, a biotechnology company focused on commercializing therapeutics for neurodegenerative diseases and trauma treatment, as well as developing innovative dietary ingredients. Previously, Kiley worked as a Financial Analyst at Hubbard Investments, LLC, and the Biomedical Research Foundation of NW Louisiana, after gaining valuable experience as an Analyst in Corporate Client Banking at JPMorgan Chase. Kiley also served as a Teaching Assistant in Corporate Finance at Tulane University, where they earned a Master of Finance. Kiley completed a Bachelor of Science in Finance at Louisiana Tech University and held the position of Vice President of the Financial Management Association, expanding its membership significantly.